BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31416576)

  • 1. Meta-analysis of chromosomal aberrations as a biomarker of exposure in healthcare workers occupationally exposed to antineoplastic drugs.
    Roussel C; Witt KL; Shaw PB; Connor TH
    Mutat Res Rev Mutat Res; 2019; 781():207-217. PubMed ID: 31416576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of genotoxicity induced by exposure to antineoplastic drugs in lymphocytes of oncology nurses and pharmacists.
    El-Ebiary AA; Abuelfadl AA; Sarhan NI
    J Appl Toxicol; 2013 Mar; 33(3):196-201. PubMed ID: 21935972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The meta-analysis of cytogenetic biomarkers as an assessment of occupational risk for healthcare workers exposed to antineoplastic drugs.
    Huang H; Gu Y; Liu S; Hu S; Zhong X; Huang Y; Peng J; Huang X
    Int Arch Occup Environ Health; 2023 Aug; 96(6):785-796. PubMed ID: 37079056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of genotoxic risks in Croatian health care workers occupationally exposed to cytotoxic drugs: a multi-biomarker approach.
    Kopjar N; Garaj-Vrhovac V; Kasuba V; Rozgaj R; Ramić S; Pavlica V; Zeljezić D
    Int J Hyg Environ Health; 2009 Jul; 212(4):414-31. PubMed ID: 19049854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal aberrations and micronucleus frequency in nurses occupationally exposed to cytotoxic drugs.
    Anwar WA; Salama SI; el Serafy MM; Hemida SA; Hafez AS
    Mutagenesis; 1994 Jul; 9(4):315-7. PubMed ID: 7968572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of chromosomal aberrations, micronuclei and proliferation rate index in peripheral lymphocytes from Tunisian nurses handling cytotoxic drugs.
    Bouraoui S; Brahem A; Tabka F; Mrizek N; Saad A; Elghezal H
    Environ Toxicol Pharmacol; 2011 Jan; 31(1):250-7. PubMed ID: 21787692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An investigation on the chromosomal damage in nurses occupationally exposed to antineoplastic drugs].
    Xu SJ; Wang JX; Yang DP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):119-20. PubMed ID: 12839665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up study of the genetic damage in lymphocytes of pharmacists and nurses handling antineoplastic drugs evaluated by cytokinesis-block micronuclei analysis and single cell gel electrophoresis assay.
    Maluf SW; Erdtmann B
    Mutat Res; 2000 Nov; 471(1-2):21-7. PubMed ID: 11080657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupational exposure to cytostatic/antineoplastic drugs and cytogenetic damage measured using the lymphocyte cytokinesis-block micronucleus assay: A systematic review of the literature and meta-analysis.
    Villarini M; Gianfredi V; Levorato S; Vannini S; Salvatori T; Moretti M
    Mutat Res Rev Mutat Res; 2016; 770(Pt A):35-45. PubMed ID: 27894689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical review and meta-analysis of epidemiology studies of occupationally exposed styrene workers evaluated for chromosomal aberration incidence.
    Collins JJ; Moore M
    Mutat Res Genet Toxicol Environ Mutagen; 2021; 861-862():503275. PubMed ID: 33551094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of chromosomal aberrations and DNA damage in a group of workers exposed to formaldehyde.
    Costa S; Carvalho S; Costa C; Coelho P; Silva S; Santos LS; Gaspar JF; Porto B; Laffon B; Teixeira JP
    Mutagenesis; 2015 Jul; 30(4):463-73. PubMed ID: 25711496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations.
    Burgaz S; Karahalil B; Canhi Z; Terzioglu F; Ançel G; Anzion RB; Bos RP; Hüttner E
    Hum Exp Toxicol; 2002 Mar; 21(3):129-35. PubMed ID: 12102538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric project.
    Moretti M; Bonfiglioli R; Feretti D; Pavanello S; Mussi F; Grollino MG; Villarini M; Barbieri A; Ceretti E; Carrieri M; Buschini A; Appolloni M; Dominici L; Sabatini L; Gelatti U; Bartolucci GB; Poli P; Stronati L; Mastrangelo G; Monarca S
    BMC Public Health; 2011 Mar; 11():195. PubMed ID: 21450074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological response to the continuous occupational exposure to antineoplastic drugs and radionuclides.
    Pajic J; Milovanovic APS
    Int J Radiat Biol; 2023; 99(12):1934-1947. PubMed ID: 37498230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal damage among medical staff occupationally exposed to volatile anesthetics, antineoplastic drugs, and formaldehyde.
    Musak L; Smerhovsky Z; Halasova E; Osina O; Letkova L; Vodickova L; Polakova V; Buchancova J; Hemminki K; Vodicka P
    Scand J Work Environ Health; 2013 Nov; 39(6):618-30. PubMed ID: 23525098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms.
    Testa A; Giachelia M; Palma S; Appolloni M; Padua L; Tranfo G; Spagnoli M; Tirindelli D; Cozzi R
    Toxicol Appl Pharmacol; 2007 Aug; 223(1):46-55. PubMed ID: 17631926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antineoplastic drugs as a potential risk factor in occupational settings: mechanisms of action at the cell level, genotoxic effects, and their detection using different biomarkers].
    Kopjar N; Zeljezić D; Kasuba V; Rozgaj R
    Arh Hig Rada Toksikol; 2010 Mar; 61(1):121-46. PubMed ID: 20338875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic consequences after occupational exposure to antineoplastic drugs.
    Fucic A; Jazbec A; Mijic A; Seso-Simic D; Tomek R
    Mutat Res; 1998 Aug; 416(1-2):59-66. PubMed ID: 9725992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approach.
    Moretti M; Grollino MG; Pavanello S; Bonfiglioli R; Villarini M; Appolloni M; Carrieri M; Sabatini L; Dominici L; Stronati L; Mastrangelo G; Barbieri A; Fatigoni C; Bartolucci GB; Ceretti E; Mussi F; Monarca S
    Int Arch Occup Environ Health; 2015 Aug; 88(6):683-95. PubMed ID: 25362515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic damage in coal and uranium miners.
    da Silva FMR; Tavella RA; Fernandes CLF; Dos Santos M
    Mutat Res Genet Toxicol Environ Mutagen; 2021 Jun; 866():503348. PubMed ID: 33985692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.